Publications by authors named "Ian Wilding"

Claim this Profile
S
Surge Dose Formulations of NSAIDs Provide for Ultra-Rapid and Consistent Drug Absorption in Both the Fasted and Fed State as Predicted by Physiologically Based Biopharmaceutics Modelling.
Harri Dickinson, Zhixin Jiang, Paul A Dickinson, Ian R Wilding, Geraldine A Elliott

Pharmaceutics· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Model-Informed Drug Development of a Controlled-Release Formulation of Nonracemic Amisulpride that Reduces Plasma Exposure but Achieves Pharmacodynamic Bioequivalence in the Brain.
Seth C Hopkins, Siriporn Toongsuwan, Taryn J Corriveau, Takao Watanabe, Yuki Tsushima, Ian Wilding

Clin Pharmacol Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of regional gastrointestinal absorption of edoxaban using the enterion capsule.
Dolly A Parasrampuria, Taro Kanamaru, Alyson Connor, Ian Wilding, Koichiro Ogata

J Clin Pharmacol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacoscintigraphy studies to assess the feasibility of a controlled release formulation of ziprasidone.
Avinash G Thombre, Sheri L Shamblin, Bimal K Malhotra, Alyson L Connor, Ian R Wilding

J Control Release· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of tacrolimus absorption from the human intestinal tract: open-label, randomized, 4-way crossover study.
Daisuke Tsunashima, Akio Kawamura, Manabu Murakami, Taiji Sawamoto, Nas Undre, Ian Wilding

Clin Ther· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a gastric retentive system as a sustained-release formulation of pranlukast hydrate and its subsequent in vivo verification in human studies.
Hikaru Sugihara, Yuji Matsui, Hirofumi Takeuchi, Ian Wilding, Alyson Connor

Eur J Pharm Sci· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of oral extended release formulations of 6-hydroxybuspirone.
Sarah J Nicholson, Peter Timmins, Randy C Dockens, Alyson Connor, Robert Croop, Ian Wilding

Biopharm Drug Dispos· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers.
Armel Stockis, Maria Laura Sargentini-Maier, Christian Otoul, Alyson Connor, Ian Wilding

Clin Ther· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of nevirapine bioavailability from targeted sites in the human gastrointestinal tract.
Sreeraj Macha, Chan-Loi Yong, Thomas R MacGregor, Mark Castles, Anne-Marie Quinson, Ian Wilding

J Clin Pharmacol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The assessment of human regional drug absorption of free acid and sodium salt forms of acipimox, in healthy volunteers, to direct modified release formulation strategy.
Rajeev Menon, Eugenio Cefali, Ian Wilding, Heather Wray, Alyson Connor

Biopharm Drug Dispos· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes.
Helle Linnebjerg, Soomin Park, Prajakti A Kothare, Michael E Trautmann, Kenneth Mace, Ian Wilding

Regul Pept· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic availability of the active metabolite hydroxy-fasudil after administration of fasudil to different sites of the human gastrointestinal tract.
Peter H Hinderling, Adel H Karara, Ben Tao, Maria Pawula, Ian Wilding

J Clin Pharmacol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved early clinical development through human microdosing studies.
Ian R Wilding, J Angus Bell

Drug Discov Today· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo disintegration profiles of encapsulated and nonencapsulated sumatriptan: gamma scintigraphy in healthy volunteers.
Ian R Wilding, Darren Clark, Heather Wray, Jeff Alderman, Nancy Muirhead

J Clin Pharmacol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remote controlled capsules in human drug absorption (HDA) studies.
Ian R Wilding, David V Prior

Crit Rev Ther Drug Carrier Syst· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Summary workshop report: biopharmaceutics classification system--implementation challenges and extension opportunities.
James E Polli, Lawrence X Yu, Jack A Cook, Gordon L Amidon, Ronald T Borchardt, Ian Wilding

J Pharm Sci· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scintigraphic evaluation of a novel colon-targeted delivery system (CODES) in healthy volunteers.
Masataka Katsuma, Shunsuke Watanabe, Shigeo Takemura, Kazuhiro Sako, Toyohiro Sawada, Ian R Wilding

J Pharm Sci· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules.
Ewart T Cole, Robert A Scott, Dominique Cade, Alyson L Connor, Ian R Wilding

Pharm Res· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of lumiracoxib bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy.
Ian R Wilding, Alyson L Connor, Polly Carpenter, Christiane Rordorf, Janice Branson

Pharm Res· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and delivery of the anti-influenza prodrug oseltamivir to the small intestine and colon using site-specific delivery capsules.
Charles Oo, Paul Snell, Joanne Barrett, Albert Dorr, Baolian Liu, Ian Wilding

Int J Pharm· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacoscintigraphic assessment of the regional drug absorption of the dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, M100240, in healthy volunteers.
Nancy E Martin, Kathryn R Collison, Louis L Martin, Sarah Tardif, Ian Wilding

J Clin Pharmacol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New developments in radionuclide imaging for assessing drug delivery in man.
Stephen P Newman, Peter H Hirst, Ian R Wilding

Eur J Pharm Sci· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequivalence testing for locally acting gastrointestinal products: what role for gamma scintigraphy?
Ian Wilding

J Clin Pharmacol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of ileal brake activators on the oral bioavailability of atenolol in man.
Clair L Dobson, Stanley S Davis, Sushil Chauhan, Robert A Sparrow, Ian R Wilding

Int J Pharm· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enteric coated HPMC capsules designed to achieve intestinal targeting.
Ewart T Cole, Robert A Scott, Alyson L Connor, Ian R Wilding, Hans U Petereit

Int J Pharm· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis